Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2

• Main Authors: Hualou Liang (Author), Liang Zhao (Author), Xiajing Gong (Author), Meng Hu (Author), Hongbin Wang (Author)
• Format: Book
• Published: Wiley, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract The outbreak of the novel coronavirus severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2), the causative agent of coronavirus disease 2019 (COVID‐19) respiratory disease, led to a global pandemic with high morbidity and mortality. Despite frenzied efforts in therapeutic development...